Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Sanara MedTech Inc.
Bear Case (25th pct.)
-88.0% vs price
Base Case (Median)
-80.7% vs price
Bull Case (75th pct.)
-77.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1.66 | -95.2% | High (40%) |
| EV/EBITDA | $9.34 | -73.3% | Medium (20%) |
| EV/FCF | $6.75 | -80.7% | Medium (20%) |
Based on 3 out of 7 methods, SMTI appears overvalued at the current price of $34.92. The base case fair value of $6.75 implies 80.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.